Ten Developments in the Use of Biologicals for Systemic Lupus Erythematosus

被引：1
|
作者：
Wallace, Daniel J. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA
来源：
CURRENT RHEUMATOLOGY REPORTS | 2013年 / 15卷 / 07期
关键词：
Biologicals; Targeted therapy; Systemic lupus erythematosus; SLE; FDA; Treatment; Cutaneous lupus; Belimumab; Epratuzumab; T cell inhibition; B-LYMPHOCYTE STIMULATOR; DOUBLE-BLIND; DISEASE-ACTIVITY; PHASE-I; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; SAFETY; BELIMUMAB; EFFICACY; RITUXIMAB;
D O I：
10.1007/s11926-013-0337-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Belimumab has recently been approved, and several other types of biological therapy with different mechanisms of action are currently in phase II and III studies. This review puts these approaches in context, emphasizing mechanistic categories and clinical trial designs. Most of the promising approaches involve B cell depletion or modulation. Post-approval experience with belimumab is critically reviewed.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Ten Developments in the Use of Biologicals for Systemic Lupus Erythematosus
    Daniel J. Wallace
    Current Rheumatology Reports, 2013, 15
  • [2] Biologicals for the treatment of systemic lupus erythematosus?
    Gunnarsson, Iva
    van Vollenhoven, Ronald F.
    ANNALS OF MEDICINE, 2012, 44 (03) : 225 - 232
  • [3] New developments in systemic lupus erythematosus
    Tsang-A-Sjoe, Michel W. P.
    Bultink, Irene E. M.
    RHEUMATOLOGY, 2021, 60 : 21 - 28
  • [4] Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies
    Leone, Alessia
    Sciascia, Savino
    Kamal, Ameer
    Khamashta, Munther
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (01) : 109 - 116
  • [5] New developments in the treatment of systemic lupus erythematosus
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2012, 27 (05) : 727 - 732
  • [6] Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
    Basta, Fabio
    Fasola, Federica
    Triantafyllias, Konstantinos
    Schwarting, Andreas
    RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 433 - 446
  • [7] Targeted therapies in systemic lupus erythematosus
    Grech, P.
    Khamashta, M. A.
    LUPUS, 2013, 22 (10) : 978 - 986
  • [8] In-/off-label use of biologic therapy in systemic lupus erythematosus
    Gatto, Mariele
    Kiss, Emese
    Naparstek, Yaakov
    Doria, Andrea
    BMC MEDICINE, 2014, 12
  • [9] Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies
    Fattah, Zozik
    Isenberg, David A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (03) : 311 - 326
  • [10] Belimumab in systemic lupus erythematosus: a perspective review
    Hui-Yuen, Joyce S.
    Li, Xiao Q.
    Askanase, Anca D.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2015, 7 (04) : 115 - 121
12345